Physician profile
William B Edmonds
NPI 1770581506
$3,250.42
in general payments reported to CMS, 2019-2025
11 companies · $426 in 2025
The $426 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $119 · 2021: $74.55 · 2022: $1,954 · 2023: $193 · 2024: $370 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $990.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $989.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,756.68 | 2022 | |
| Stryker Corporation | $661.84 | 2022-2025 | Valor, Easyfuse, Fixos |
| Pylant Medical | $271.38 | 2020-2022 | |
| Bone Support INC. | $185.27 | 2024 | Cerament G, Ceramentbone Void Filler |
| Biotissue Holdings INC. | $147.41 | 2025 | |
| Wright Medical Technology, INC. | $100.45 | 2019 | |
| Innovation Technologies INC | $49.73 | 2023-2024 | Irrisept |
| Treace Medical Concepts, INC. | $28.24 | 2025 | |
| Bioventus LLC | $25.07 | 2021 | |
| Medtronic USA, INC. | $12.36 | 2019 | |
| Merck Sharp & Dohme LLC | $11.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Edmonds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.